Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

INTRODUCTION: Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue damage, and cancer. However, the use of mesenchymal stem cells (MSCs) to trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Atsuta, Ikiru, Liu, Shiyu, Miura, Yasuo, Akiyama, Kentaro, Chen, Chider, An, Ying, Shi, Songtao, Chen, Fa-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854680/
https://www.ncbi.nlm.nih.gov/pubmed/24025590
http://dx.doi.org/10.1186/scrt322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854680/
https://www.ncbi.nlm.nih.gov/pubmed/24025590
http://dx.doi.org/10.1186/scrt322

Ejemplares similares